Lyra Therapeutics, Inc. (LYRA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-18.62 | +74.0% |
| 2024 | $-71.75 | -5594.4% |
| 2023 | $-1.26 | +31.1% |
| 2022 | $-1.83 | +45.4% |
| 2021 | $-3.35 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-18.62 | +74.0% |
| 2024 | $-71.75 | -5594.4% |
| 2023 | $-1.26 | +31.1% |
| 2022 | $-1.83 | +45.4% |
| 2021 | $-3.35 | — |